Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Reinstates Buy on Nucor, Announces $172 Price Target

B of A Securities analyst Lawson Winder reinstates Nucor (NYSE:NUE) with a Buy and announces $172 price target.
byBenzinga Newsdesk
January 4, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

B of A Securities analyst Lawson Winder reinstates Nucor (NYSE:NUE) with a Buy and announces $172 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Vigil Neuroscience, Inc. Has Received A Response Letter From The FDA Regarding The Partial Clinical Hold On Its Drug VG-3927, Stating That Additional Non-Clinical Data Is Needed To Exceed The Maximum Exposure Limit In The Phase 1 Trial

By Benzinga Newsdesk
October 12, 4:15 PM
- SEC FilingOn Thursday, October 12, 2023, Vigil Neuroscience, Inc. (the "Company") provided an update on the Company's small molecule TREM2 agonist, VG-3927. The Company announced that it received the 30-day

VIGL